Patent: 5,854,051
✉ Email this page to a colleague
Summary for Patent: 5,854,051
| Title: | Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof |
| Abstract: | The present invention relates to: parasitic helminth asparaginase proteins; parasitic helminth asparaginase nucleic acid molecules, including those that encode such asparaginase proteins; antibodies raised against such asparaginase proteins; and compounds that inhibit parasitic helminth asparaginase activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to protect animals from diseases caused by parasitic helminths. |
| Inventor(s): | Chandrashekar; Ramaswamy (Fort Collins, CO), Tsuji; Naotoshi (Fort Collins, CO) |
| Assignee: | Heska Corporation (Fort Collins, CO) Colorado State University Research Foundation (Fort Collins, CO) |
| Application Number: | 08/929,501 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,854,051
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2039-03-29 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
